Extensive

Male Humans Prostate-Specific Antigen Prostatic Neoplasms, Castration-Resistant / radiotherapy Dipeptides Kidney / pathology Lutetium / therapeutic use Thrombotic Microangiopathies Treatment Outcome
(177)Lu-PSMA Chronic kidney disease Metastatic castration-resistant prostate cancer Prostate cancer Radiation nephropathy Radioligand therapy Renal toxicity Theranostics Thrombotic microangiopathy Tubulotoxicity

Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
05 2023
Historique:
received: 08 02 2022
revised: 08 05 2022
accepted: 26 05 2022
medline: 18 4 2023
pubmed: 11 6 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

Lutetium-177 prostate-specific membrane antigen (

Identifiants

DOI: 10.1016/j.eururo.2022.05.025 PMID: 35688660
pubmed: 35688660
pii: S0302-2838(22)02401-0
doi: 10.1016/j.eururo.2022.05.025
pii:
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77
Dipeptides 0
Lutetium 5H0DOZ21UJ

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-390

Informations de copyright

Copyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Hannah Schäfer (H)

Department of Nephrology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany. Electronic address: hannah.schaefer@mri.tum.de.

Sarah Mayr (S)

Department of Nephrology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Maike Büttner-Herold (M)

Department of Nephropathology, Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.

Karina Knorr (K)

Department of Nuclear Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Lisa Steinhelfer (L)

Department of Nuclear Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Carsten A Böger (CA)

Department of Nephrology, Diabetology and Rheumatology, Hospital Traunstein, Traunstein, Germany; KfH Kidney Center Traunstein, Traunstein, Germany; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.

Jürgen E Gschwend (JE)

Department of Urology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Uwe Heemann (U)

Department of Nephrology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Matthias Eiber (M)

Department of Nuclear Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Christoph Schmaderer (C)

Department of Nephrology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Robert Tauber (R)

Department of Urology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany. Electronic address: robert.tauber@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Extensive
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Antigène spécifique de la prostate › Extensive
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Tumeurs prostatiques résistantes à la castration › Extensive
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Oligopeptides › Dipeptides › Extensive
questionsmedicales.fr › Appareil urogénital › Voies urinaires › Rein › Extensive
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Terres rares › Lanthanides › Lutétium › Extensive
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Hémopathies › Anomalies des plaquettes › Thrombopénie › Microangiopathies thrombotiques › Extensive
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Extensive